Furthermore, although the reported FAS inhibitors, such as C75, cerulenin, α-mangostin, and resveratrol, have distinct structures, chemical properties, inhibitory mechanisms, and reaction sites on FAS, they all exhibit common effects: decreased viability in cancer cells [18,38,39]. The gene discussed is FAS; the disease is cancer.